Literature DB >> 15867425

Clonal expansion of a new MLL rearrangement in the absence of leukemia.

Oliver Teuffel, David R Betts, Marco Thali, Dominique Eberle, Claus Meyer, Björn Schneider, Rolf Marschalek, Luba Trakhtenbrot, Ninette Amariglio, Felix K Niggli, Beat W Schäfer.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15867425     DOI： 10.1182/blood-2005-01-0286

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Therapy-related acute myeloid leukemia 6 years after clonal detection of inv(11)(q21q23) and MLL gene rearrangement.

Authors:  Naoko Takei; Kazumi Suzukawa; Harumi Yamamoto Mukai; Takayoshi Itoh; Yasushi Okoshi; Yasuhiro Yoda; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.

Authors:  Brian H Kushner; Kim Kramer; Shakeel Modak; Li-Xuan Qin; Karima Yataghena; Suresh C Jhanwar; Nai-Kong V Cheung
Journal:  Pediatr Blood Cancer       Date:  2009-07       Impact factor: 3.167

3.  The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia.

Authors:  Shoichi Kobayashi; Masato Obata; Maki Hagihara; Kenji Motohashi; Satomi Ito; Rika Ohshima; Rika Sakai; Atsuo Maruta; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2009-11-20       Impact factor: 2.490

4.  Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.

Authors:  Blaine W Robinson; Nai-Kong V Cheung; Christos P Kolaris; Suresh C Jhanwar; John K Choi; Neil Osheroff; Carolyn A Felix
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.